BAJAJ BROKING

Notification close image
No new Notification messages
card image
Travel Food Services IPO is Open!
Apply for the Travel Food Services IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Asston Pharmaceuticals Ltd

Pharmaceuticals

Offer Period :

9th to 11th Jul 2025

Asston Pharmaceuticals Ltd IPO Details

IPO Date 9th to 11th Jul 2025 Minimum Investment ₹123000 / 2 Lots
Listing Date 2025-07-16 Maximum Investment ₹123000 / 1 Lots
Face Value ₹10 per share Total Issue Size ₹27.56 Crores
Price ₹115 to ₹123 per share Fresh Issue ₹27.56 Crores
Lot Size 1 Lots (1000 Shares) Offer For Sale ₹ [-]
Listing At BSE-SME Retail Discount ₹ 0
Employee Discount ₹0 per Share Shareholding Pre Issue 6271360 Shares
Issue Type Book Building - SME Shareholding Post Issue 8512960 Shares
IPO Date 9th to 11th Jul 2025
Listing Date 2025-07-16
Face Value ₹10 per share
Price ₹115 to ₹123 per share
Lot Size 1 Lots (1000 Shares)
Listing At BSE-SME
Total Issue Size ₹27.56 Crores
Employee Discount ₹0 per share
Issue Type Book Building - SME
Minimum Investment ₹123000 / 2 Lots
Maximum Investment ₹123000 / 1 Lots
Fresh Issue ₹27.56 Crores
Offer For Sale ₹[-] Crores
Retail Discount ₹0 Crores
Shareholding Pre Issue 6271360 Shares
Shareholding Post Issue 8512960 Shares

About Asston Pharmaceuticals Ltd IPO

Founding Head:

Managing Director: Ashish Narayan Sakalkar

Asston Pharmaceuticals Limited Timeline

Important dates for allocation and IPO listing.

9th Jul

IPO Opens

11th Jul

IPO Close

14th Jul

Allotment Date

15th Jul

Initiation of Refund

15th Jul

Credit of Shares to Demat Account

16th Jul

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 0 0
Public Group 0 0

Asston Pharmaceuticals Ltd IPO Reservation

QIB Shares Offered 0(0%)
NII (HNI) Shares Offered 0(0%)
Retail Shares Offered 0(0%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

Asston Pharmaceuticals Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1000 ₹123000
Retail (Max) 1 1000 ₹123000
S HNI (Min) 2 2000 ₹246000
S HNI (Max) 8 8000 ₹984000
B HNI (MIN) 9 9000 ₹1107000

Asston Pharmaceuticals Ltd IPO Anchor Investor Details

Bid Date 08 July 2025
Shares Offered 0
Anchor Portion Size 0

Asston Pharmaceuticals Ltd IPO Registrar

Maashitla Securities Pvt Ltd
Phone Number +91 11 47581432
Email Id ipo@maashitla.com
Our Website www.maashitla.com

Asston Pharmaceuticals Ltd IPO Lead Manager

1. Sobhagya Capital Options Pvt. Ltd.

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Asston Pharmaceuticals Ltd Financial Information

Period Ended March 31, 2024 March 31, 2023 March 31, 2022
Net Worth ₹6.39 ₹1.99 ₹0.93
Reserves and Surplus ₹5.61 ₹1.29 ₹0.23
Total Borrowing ₹6.82 ₹5.25 ₹3.31

Asston Pharmaceuticals Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 0 0 0
Non Institutional Investors (NIIs) 0 0 0
NII(Bid amount of more than Ten Lakh Rupees) 0 0 0
NII(Bid amount of more than 2 Lakh < 10 Rupees) 0 0 0
Retail Individual Investors (RIIs) 0 0 0
Total 0 0 0

Strength of Asston Pharmaceuticals Ltd

1. Formulation Expertise.

2. Experienced Promoters.

3. Wide range of Products.

4. Strategic Location.

5. Skilled Workforce.

6. Good relationship with contract manufacturers.

7. Quality Assurance.

8. Good relationship with clients in the export market.

9. Competitive Pricing.

10. Asset Light Model.

Risks Involved

1. The Company operates in pharmaceutical sector, which is extensively regulated, any failures on its part to comply with the existing and future statutory and/or regulatory requirements in the pharmaceutical sector could adversely affect its business, results of operations and financial condition.

2. The company operate its own manufacturing facility for pharmaceutical products; however for certain products other than tablets, the company relies on third-party manufacturers to procure the pharmaceutical products.

3. The company depends on the success of its relationships with the company customers. The company derives a significant part of its revenue from its major customers and the company does not have long-term contracts with these customers other than contracts with 2 customers for one year. If one or more of such customers choose not to source their requirements from it, the company business, financial condition and results of operations may be adversely affected.

4. The loss of contract manufacturing tie-ups and the low entry barrier for contract manufacturing can affect production, order intake, revenue, cash flow, and profitability. The absence of exclusive agreements increases the risk of delays or disruptions in order execution, further impacting business operations.

5. The company has substantial working capital expenditure and may requires additional financing to meet those requirements and have risk of receivables, which could have an adverse effect on its results of operations and financial condition.

6. The property used by the Company for the purpose of its Registered Office and factory is not owned by the company. Any termination of the relevant lease agreement in connection with such property or the company failures to renew the same could adversely affect its operations.

7. The company success largely depends upon the knowledge and experience of its Promoters, Directors, the company Key Managerial Personnel and Senior Management as well as its ability to attract and retain personnel with technical expertise. Any loss of the company Promoter, Directors, Key Managerial Personnel, Senior Management or its ability to attract and retain them and other personnel with technical expertise could adversely affect its business, financial condition and results of operations.

8. If the company is not able to attract and retain sufficient qualified and trained personnel at the Company which may adversely affect its business.

9. The company has been recently converted into public limited company and any non-compliance with the provisions of Companies Act, 2013 may attract penalties against the Company which could impact its financial and operational performance and reputation.

10. All its manufacturing facilities are situated at Ambernath, Thane, Maharashtra resulting in concentration in a single region. Any interruption for a significant period of time, in these facilities may in turn adversely affect its business, financial condition and results of operations.

Why should you invest in

-

Asston Pharmaceuticals Ltd Financials

Particulars For the financial year ending (in ₹ million)
 
Total Assets
Total Liabilities
Total Expenses
Total Revenue 
Profit After Tax
EBITDA
Adjusted EBITDA

Asston Pharmaceuticals Limited IPO Contact Details

Asston Pharmaceuticals Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2025-07-16 0 -
INE0SJX01015
₹0 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹115 ₹0
Open ₹0 ₹0
Low ₹0 ₹0
High ₹0 ₹0
Low ₹0 ₹0

Frequently Asked Questions

What is Asston Pharmaceuticals Ltd IPO?

Answer Field

Asston Pharmaceuticals Ltd IPO is a SME IPO of [-] equity shares of a face value of ₹10 aggregating up to ₹27.56 Crores. The issue is priced at ₹115 to ₹123 per share. The minimum order quantity is 1000 Shares. The IPO opens on July 09, 2025, and closes on July 11, 2025. Maashitla Securities Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE-SME.

When Asston Pharmaceuticals Ltd IPO will open?

Answer Field

The Asston Pharmaceuticals Ltd IPO opens on July 09, 2025 and closes on July 11, 2025.

What is the lot size of Asston Pharmaceuticals Ltd?

Answer Field

Asston Pharmaceuticals Ltd lot size is 1000 shares, and the minimum amount required is ₹1,23,000.

How to apply for Asston Pharmaceuticals Ltd IPO?

Answer Field

You can apply in Asston Pharmaceuticals Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Asston Pharmaceuticals Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Asston Pharmaceuticals Ltd IPO will be done on July 14, 2025, and the allotted shares will be credited to your demat account by July 15, 2025.

When is Asston Pharmaceuticals Ltd IPO listing date?

Answer Field

The Asston Pharmaceuticals Ltd listing date is July 16, 2025.

Who is the registrar of Asston Pharmaceuticals Ltd IPO?

Answer Field

The registrar of Asston Pharmaceuticals Ltd IPO is Maashitla Securities Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Sobhagya Capital Options Pvt. Ltd. will be the book-running lead manager of this IPO.

What is the fresh issue of Asston Pharmaceuticals Ltd IPO?

Answer Field

The fresh issue size is ₹27.56 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Asston Pharmaceuticals Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1000 shares and ₹1,23,000 amount.

How can I approve the UPI mandate request for Asston Pharmaceuticals Ltd IPO?

Answer Field

To apply for Asston Pharmaceuticals Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Asston Pharmaceuticals Ltd?

Answer Field

The price of each Asston Pharmaceuticals Ltd share will be ranging in between ₹115 to ₹123 per share.

What is the cut-off time for the UPI mandate for Asston Pharmaceuticals Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, July 11, 2025.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • CRIZAC LIMITEDMainboard IPO

  • Bidding Dates

    2nd Jul 2025 - 7th Jul 2025

  • Price Range

    ₹233.0 - 245.0

  • IPO Size

    ₹8,60,00,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • NEETU YOSHI LIMITEDSME IPO

  • Issue Price

    75.00

  • Listing Day Close

    110.25

  • Listing Day (Gain/Loss)

    46.67

  • PRO FX TECH LIMITEDSME IPO

  • Issue Price

    87.00

  • Listing Day Close

    99.75

  • Listing Day (Gain/Loss)

    14.94

  • SUPERTECH EV LIMITEDSME IPO

  • Issue Price

    92.00

  • Listing Day Close

    69.92

  • Listing Day (Gain/Loss)

    -23.91

  • RAMA TELECOM LIMITEDSME IPO

  • Issue Price

    68.00

  • Listing Day Close

    68.40

  • Listing Day (Gain/Loss)

    0.00

  • KALPATARU LIMITEDMainboard IPO

  • Issue Price

    414.00

  • Listing Day Close

    433.80

  • Listing Day (Gain/Loss)

    4.83

  • ABRAM FOOD LIMITEDSME IPO

  • Issue Price

    98.00

  • Listing Day Close

    94.92

  • Listing Day (Gain/Loss)

    -3.06

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.2 App Rating

icon-with-text

4 Languages

icon-with-text

₹5600+ Cr MTF Book

icon-with-text